JACQUES JM
VAN DONGEN
Investigador
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (4)
2016
-
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30
2009
-
New insights to the MLL recombinome of acute leukemias
Leukemia, Vol. 23, Núm. 8, pp. 1490-1499
2005
-
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence
Cancer, Vol. 104, Núm. 7, pp. 1442-1452
2002
-
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
Leukemia, Vol. 16, Núm. 9, pp. 1627-1636